Expression of the epidermal growth factor system in endometrial cancer after adjuvant tamoxifen treatment for breast cancer.

@article{Androutsopoulos2006ExpressionOT,
  title={Expression of the epidermal growth factor system in endometrial cancer after adjuvant tamoxifen treatment for breast cancer.},
  author={Georgios Androutsopoulos and Georgios G Adonakis and Maria Gkermpesi and Panagiotis Gkogkos and Panagiota Ravazoula and George Kourounis},
  journal={European journal of gynaecological oncology},
  year={2006},
  volume={27 5},
  pages={490-4}
}
The aim of our study was to describe the expression of cerbB-1, cerbB-2, cerbB-3 and cerbB-4 in endometrial cancer tissue and its correlation with clinicopathologic features and prognosis of endometrial cancer patients diagnosed during or after tamoxifen treatment for breast cancer. Thirteen tamoxifen-related endometrial cancers were identified from the archives of the Department of Obstetrics and Gynecology of the University of Patras, Medical School. Tissue specimens from endometrial lesions… CONTINUE READING

Similar Papers

Loading similar papers…